These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25453357)

  • 1. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
    Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France].
    de la Taille A; Desgrandchamps F; Saussine C; Lukacs B; Haillot O
    Prog Urol; 2004 Jun; 14(3):320-5. PubMed ID: 15373173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical and interventional management of benign prostatic obstruction: Guidelines from the Committee for Male Voiding Disorders of the French Urology Association].
    Lebdai S; Chevrot A; Doizi S; Pradère B; Barry Delongchamps N; Baumert H; Benchikh A; Della Negra E; Fourmarier M; Gas J; Misraï V; Rouscoff Y; Theveniaud PE; Vincendeau S; Wilisch J; Descazeaud A; Robert G;
    Prog Urol; 2021 Apr; 31(5):249-265. PubMed ID: 33478868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of visual prostate symptom score, VPSS, in the evaluation of lower urinary tract symptoms associated with benign prostatic hyperplasia (550 patients)].
    Descazeaud A; Coloby P; Davin JL; De La Taille A; Karsenty G; Kouri G; Rossi D; Pouteau JC; Zerbib M
    Prog Urol; 2017 Mar; 27(3):176-183. PubMed ID: 28285780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical impact of the intravesical prostatic protrusion: a review by the LUTS committee of the French Urological Association].
    Lebdai S; Ammi M; Bigot P; Cornu JN; Mathieu R; Descazeaud A; Azzouzi AR;
    Prog Urol; 2014 Apr; 24(5):313-8. PubMed ID: 24674338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.
    Seftel AD; Rosen RC; Rosenberg MT; Sadovsky R
    Int J Clin Pract; 2008 Apr; 62(4):614-22. PubMed ID: 18266709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of a systematic assessment of the treatment of the lower urinary tract symptoms in the management of benign prostatic hypertrophy in general practice (1380 patients) - Study EVALURO].
    Descazeaud A; Coloby P; De La Taille A; Kouri G; Mallet R; Rossi D; Rozet F; Zerbib M; Carrois F
    Prog Urol; 2019 Feb; 29(2):116-126. PubMed ID: 30665818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited.
    Juliao AA; Plata M; Kazzazi A; Bostanci Y; Djavan B
    Curr Opin Urol; 2012 Jan; 22(1):34-9. PubMed ID: 22123290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.
    Paick JS; Kim SW; Ku JH
    Yonsei Med J; 2007 Apr; 48(2):281-8. PubMed ID: 17461528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.
    Strope SA; Elliott SP; Saigal CS; Smith A; Wilt TJ; Wei JT;
    Urology; 2011 Jul; 78(1):3-9. PubMed ID: 21601254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benign prostatic hyperplasia (BPH): prevalence in general practice and practical approach of French general practitioners. Results of a study based on 17,953 patients].
    Costa P; Ben Naoum K; Boukaram M; Wagner L; Louis JF
    Prog Urol; 2004 Feb; 14(1):33-9. PubMed ID: 15098749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CROATIAN UROLOGISTS' CLINICAL PRACTICE AND COMPLIANCE WITH GUIDELINES IN THE MANAGEMENT OF NON-NEUROGENIC MALE LOWER URINARY TRACT SYMPTOMS.
    Tomasković I; Tomić M; Nikles S; Neretljak I; Milicić V
    Acta Clin Croat; 2015 Dec; 54(4):453-7. PubMed ID: 27017719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
    Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
    J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serious and unexpected complications of benign prostatic obstruction surgery: Results of the LUTS Committee survey from urologists of the French Urological Association].
    Misraï V; Barry Delongchamps N; Lebdai S; Azzouzi AR; Benchikh A; Cornu JN; Dumonceau O; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Sep; 25(10):583-9. PubMed ID: 26159052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion.
    Nickel JC; Saad F
    Can J Urol; 2004 Apr; 11(2):2186-93. PubMed ID: 15182407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.